Search results
Results From The WOW.Com Content Network
Prostaglandin E 2 (PGE 2) achieves cervical ripening and softening by stimulating uterine contractions as well as directly acting on the collagenase present in the cervix to soften it. [7] There are currently two formulations of PGE 2 analog available for use in cervical ripening: Prepidil, a vaginal gel, and Cervidil, a vaginal insert. [24]
Concern has been raised that uterine hyperstimulation that occurs during a misoprostol-induced labor is more difficult to treat than hyperstimulation during labors induced by other drugs. [58] Because the complications are rare, it is difficult to determine if misoprostol causes a higher risk than do other cervical ripening agents.
Cook Medical Double Balloon known as the Cervical Ripening Balloon with Stylet for assisted placement is FDA approved. The Double balloon provides one balloon to be inflated with saline on one side of the Uterine side of the cervix and the second balloon to be inflated with saline on the vaginal side of the cervix.
Cervical ripening using dinoprostone vaginal inserts have the same rates of neonatal morbidity, caesarean section, and labor onset when used in the outpatient setting and the inpatient setting. [20] Evidence for use of misoprostol in the outpatient versus inpatient setting was insufficient to draw conclusions.
Use of mifepristone as a cervical ripening agent has been described. [169] The medication has been studied as an antiandrogen in the treatment of prostate cancer . [ 170 ] [ 171 ] Mifepristone showed no detectable anti-HIV activity in clinical trials.
Primarily known for its role in mediating inflammation: pain, swelling, redness, and warmth, prostaglandin synthesis is a target for many drugs. Inhibition of COX-1 and COX-2 by aspirin and non-steroidal anti-inflammatory drugs prevents the inflammatory response and can also prevent homeostatic functions of the stomach and GI system that may ...
The treatment, Tivdak - an antibody-drug conjugate co-developed by Genmab A/S and Seagen - received the FDA's accelerated approval for the same indication in 2021. It was added to Pfizer's ...
It causes cervical ripening, or the thinning and shortening of the cervix in preparation for birth. It also causes uterine contractions, allowing the body to expel the baby. For this purpose, it is placed inside the vagina. [8] [15]